2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Rhuepo: new trials by email Literature Review of Rhuepo trials Research Report on Rhuepo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis RD01, Recombinant Human Erythropoiesis Injection (CHO cell), placebo - Patient of Anemia in Chronic Renal Failure With Hemodialysis | Phase 2 | Unknown | Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd | 105 | 2020-03-01 | 2020-01-18 |
| Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis Recombinant Human Erythropoiesis Injection (CHO cell), Recombinant Erythropoiesis Stimulating Protein Injection(CHO cell) - Chronic Renal Failure With Hemodialysis | Phase 2 | Unknown | Shenyang Sunshine Pharmaceutical Co., LTD. | 150 | 2019-06-24 | 2020-03-09 |
Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd (1) · Shenyang Sunshine Pharmaceutical Co., LTD. (1)
China (2)